Opinion

Video

Resources and Education for Operationalizing Bispecifics

Key Takeaways

  • Institutions can utilize specialized training programs and partnerships with biotech firms to address bispecific antibody challenges.
  • Comprehensive regulatory guidance is crucial for navigating the complex approval processes associated with bispecific antibodies.
SHOW MORE

Panelists discuss how infrastructure including specialized staff training, updated protocols, enhanced monitoring systems, and comprehensive educational resources for health care providers is essential for institutions to successfully implement and optimize bispecific antibody therapies while ensuring patient safety and treatment efficacy.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
1 expert in this video
1 expert in this video
1 expert in this video
1 expert in this video
1 expert in this video
1 expert in this video
1 KOL is featured in this series.
1 expert in this video